Conception and design: All authors

Administrative support: R. Bryan Rumble

Collection and assembly of data: All authors

Data analysis and interpretation: All authors

Manuscript writing: All authors

Final approval of manuscript: All authors

Accountable for all aspects of the work: All authors

AUTHORS' DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST

Management of Metastatic Clear Cell Renal Cell Carcinoma: ASCO Guideline Q&A

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/op/authors/author-center.

Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments).

Eric A. Singer

Consulting or Advisory Role: Merck, Johnson & Johnson/Janssen, Vyriad, Aura Biosciences

Research Funding: Astellas Medivation

No other potential conflicts of interest were reported.